Think you can trust published medical research? Think again. The CLASS trial, a cornerstone of vein treatment discussions, is riddled with flaws that could be misleading you. In this eye-opening video, Dr. Haroun Gajraj dissects the CLASS trial, exposing its methodological shortcomings and challenging its conclusions about the effectiveness of laser ablation, foam sclerotherapy, and surgery for varicose veins. Discover: * Why the trial design is fundamentally flawed * How outdated foam sclerotherapy techniques skew the results * The shocking number of patients excluded from the study * The urgent need for a real debate about foam sclerotherapy's role in modern vein care **Conclusion:** Don't let outdated research dictate your treatment choices. It's time to put the CLASS trial to rest and embrace the full potential of foam sclerotherapy. **Call to Action:** Hit that play button NOW to learn the truth about vein treatments! Like, share, and subscribe to help spread the word about the importance of informed decision-making. The information presented in this video is for educational and informational purposes only and does not constitute medical advice. Please consult with a qualified healthcare professional regarding any health conditions or treatment options. Disclaimer: I am a board member of the BAS. The views and opinions expressed in this article are solely my own and are based on my personal interpretations of the available research. They do not necessarily reflect the position or views of any organization or institution I am affiliated with. I am not attacking the integrity of the authors of any publication. My intention is to start a debate. If you are interested in debating this further, post your views. This and other topics of relevance to phlebology will be debated at the BAS conference in 2025. https://www.veincare.academy/bas-2025-annual-conference 00:00 Vein Treatment: Laser, Surgery, or Foam Sclerotherapy? Debunking the CLASS Trial Myths for Doctors 00:35 Introduction to the CLASS Trial and Its Importance 03:00 Critique of the CLASS Trial's Methodology 05:57 Conclusions and Call for Debate on Foam Sclerotherapy https://www.nejm.org/doi/full/10.1056/NEJMoa1805186 👉 Check out these links 🔗🔗🔗 👀 👀 🔗 https://www.veincare.academy/bas-2025-annual-conference 🔗 https://www.veincare.academy/ 🔗 https://www.veincare.academy/freebies 🔗 https://www.veincare.academy/blog 🔗 https://www.veincare.academy/subscribe-now 🔗 https://www.veincare.academy/bas-2024-annual-conference-video-recording 🔗 https://www.veincare.academy/bas-2025-annual-conference 🔗 https://www.veincare.academy/free-guide-to-short-wave-diathermy 🔗 https://www.veincare.academy/free-guide-how-to-inject-leg-spider-veins-and-blue-veins-by-microsclerotherapy

Is Laser Better Than Microsclerotherapy? Leg Spider Vein Treatment Evidence
9 views

Why Some Spider Veins Resist Microsclerotherapy: The Role of Vessel Size and When to Change Approach
161 views

Do You NEED a Duplex Ultrasound Before Microsclerotherapy for spider veins? (What the Evidence Says)
183 views

How to Prevent Brown Marks After Microsclerotherapy (Hyperpigmentation Guide for doctors & nurses)
370 views

Microsclerotherapy & Short Wave Diathermy for Face & Leg Spider veins: "Brown Marks" & Patient Trust
145 views

Why Your Medical Website is Failing (And How to Fix it for AI)
99 views